Sotac Pharmaceuticals Limited (NSE:SOTAC)

India · Delayed Price · Currency is INR

130.00

0.00 (0.00%)

Nov 9, 2026, 11:41 AM IST

Market Cap	1.44B +0.8%
Revenue (ttm)	1.01B +1.3%
Net Income	57.67M -28.2%
EPS	5.22 -28.1%
Shares Out	11.05M
PE Ratio	24.91
Forward PE	n/a
Dividend	0.20 (0.15%)
Ex-Dividend Date	Sep 23, 2026

Volume	1,200
Open	130.00
Previous Close	130.00
Day's Range	130.00 - 130.00
52-Week Range	86.00 - 139.65
Beta	-0.18
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-lactams and non-IP-lactams), anti-fungal, and cephalosporin products. The compa... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2014

Employees 55

Stock Exchange National Stock Exchange of India

Ticker Symbol SOTAC

Full Company Profile

Financial Performance

In fiscal year 2026, Sotac Pharmaceuticals's revenue was 1.01 billion, an increase of 1.33% compared to the previous year's 999.29 million. Earnings were 57.67 million, a decrease of -28.16%.

Financial Statements